We have a trial already with a checkpoint inhibito
Post# of 155581
The trial is in combination partnership with Keytruda (pembrolizumab) in a breast cancer xenograft model.
When Jay spoke it was pretty clear that a paper should come out soon on this trial. Someone correct me if I’m wrong but this is what I gathered when he talked about publishing papers.
Cancer news in this area would be huge. The result should be complete and the results are most likely being published very soon.
https://www.biospace.com/article/embattled-cy...h-tumors-/


CytoDyn Inc (CYDY) Stock Research Links
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com